Sherri O. Stuver, ScD

Clinical Professor, Epidemiology
Sherri Stuver
Talbot – T323E
View full profile at BUMC


Dr. Stuver's research has focused on virus-associated disease and malignancy, especially those related to hepatitis C virus and human T-lymphotropic virus type I infections. She was the principal investigator of a community-based cohort study in Japan investigating viral and nonviral risk factors for progression of hepatitis C virus infection to liver damage and hepatocellular carcinoma. She currently collaborates with Dr. Lisa Fredman on her studies of the effects of stress among older caregivers and non-caregivers. Dr. Stuver also is involved in research and quality improvement projects in the Department of Quality and Patient Safety at Dana-Farber Cancer Institute, including care at the end of life and the use of supportive therapies.


  • Harvard University, ScD
  • Harvard-Radcliffe College, AB

Classes Taught

  • SPHEP813
  • SPHEP980
  • SPHEP980


  • Published on 8/4/2015

    Zerillo JA, Stuver SO, Fraile B, Dodek AD, Jacobson JO. Understanding Oral Chemotherapy Prescribing Patterns at the End of Life at a Comprehensive Cancer Center: Analysis of a Massachusetts Payer Claims Database. J Oncol Pract. 2015 Sep; 11(5):372-7. PMID: 26243650.

    Read at: PubMed
  • Published on 5/1/2015

    Rothman KJ, Stuver SO. In: Olsen J, Greene N, Saracci R, Trichopoulos D, eds. Teaching Epidemiology. Fourth Edition. Teaching a first course in epidemiologic principles and methods. Oxford University Press. London. 2015; 67-81.

  • Published on 3/1/2015

    Li JW, Morway L, Velasquez A, Weingart SN, Stuver SO. Perceptions of medical errors in cancer care: an analysis of how the news media describe sentinel events. J Patient Saf. 2015 Mar; 11(1):42-51. PMID: 24080724.

    Read at: PubMed
  • Published on 11/4/2014

    Lyons JG, Heeren T, Stuver SO, Fredman L. Assessing the agreement between 3-meter and 6-meter walk tests in 136 community-dwelling older adults. J Aging Health. 2015 Jun; 27(4):594-605. PMID: 25376604.

    Read at: PubMed
  • Published on 8/7/2014

    Oda K, Uto H, Kumagai K, Ido A, Kusumoto K, Shimoda K, Hayashi K, Stuver SO, Tanaka Y, Nishida N, Tokunaga K, Tsubouchi H. Impact of a single nucleotide polymorphism upstream of the IL28B gene in patients positive for anti-HCV antibody in an HCV hyperendemic area in Japan. J Med Virol. 2014 Nov; 86(11):1877-85. PMID: 25100136.

    Read at: PubMed
  • Published on 5/15/2013

    Fredman L, Gordon SA, Heeren T, Stuver SO. Positive affect is associated with fewer sleep problems in older caregivers but not noncaregivers. Gerontologist. 2014 Aug; 54(4):559-69. PMID: 23676301.

    Read at: PubMed
  • Published on 2/18/2013

    Tsubouchi N, Uto H, Kumagai K, Sasaki F, Kanmura S, Numata M, Moriuchi A, Oketani M, Ido A, Hayashi K, Kusumoto K, Shimoda K, Stuver SO, Tsubouchi H. Impact of antibody to hepatitis B core antigen on the clinical course of hepatitis C virus carriers in a hyperendemic area in Japan: A community-based cohort study. Hepatol Res. 2013 Nov; 43(11):1130-8. PMID: 23413835.

    Read at: PubMed
  • Published on 12/1/2012

    Edwards EM, Stuver SO, Heeren TC, Fredman L. Job strain and incident metabolic syndrome over 5 years of follow-up: the coronary artery risk development in young adults study. J Occup Environ Med. 2012 Dec; 54(12):1447-52. PMID: 23171915.

    Read at: PubMed
  • Published on 11/21/2012

    Weingart SN, Cleary A, Scullion B, Morway L, Phantumvanit V, Stuver SO, Shulman LN, Connors JM. Comparing clinicians' use of an anticoagulation management service and usual care in ambulatory oncology. J Oncol Pharm Pract. 2013 Sep; 19(3):237-45. PMID: 23175451.

    Read at: PubMed
  • Published on 11/15/2012

    Reed C, Bliss C, Stuver SO, Heeren T, Tumilty S, Horsburgh CR, Samet JH, Cotton DJ. Predictors of active injection drug use in a cohort of patients infected with hepatitis C virus. Am J Public Health. 2013 Jan; 103(1):105-11. PMID: 23153145.

    Read at: PubMed

View 80 more publications:View full profile at BUMC